Clal Insurance’s ARK Innovation ETF ARKK Stock Holding History

Clal Insurance’s Portfolio ARKK Stock Details ARKK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,203,000	Closed	-$48M	–	170
2022 Q2	$48M	Sell	1,203,000 -16,000	-1%	-$762K	0.64%	49
2022 Q1	$80.8M	Buy	+1,219,000	New	+$86M	0.85%	36

Other funds holding ARKK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SAMH

Shanda Asset Management Holdings Tortola,, British Virgin Islands $1.85B AUM 36.09% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Clal Insurance's ARKK Position: Q3 2022 in Review

Clal Insurance sold out of ARK Innovation ETF (ARKK) in Q3 2022, closing a stake of 1,203,000 shares — an estimated $48M sold.

Clal Insurance first reported a position in ARKK in Q1 2022 and held it in 2 quarters. The position peaked at $80.8M in Q1 2022. 618 funds tracked by Wall St. Rank hold ARKK as of Q3 2022.

Clal Insurance reported no remaining ARK Innovation ETF position as of Q3 2022 after selling out during the quarter.
Clal Insurance sold 1,203,000 ARK Innovation ETF shares in Q3 2022, an estimated $48M.
Clal Insurance first reported a position in ARK Innovation ETF in Q1 2022 and held it in 2 quarters.
Clal Insurance's ARK Innovation ETF position peaked at $80.8M in Q1 2022.
618 funds tracked by Wall St. Rank held ARK Innovation ETF as of Q3 2022.

Based on Clal Insurance's 13F filing for Q3 2022, filed 14 Nov 2022.